Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrp Advisory Group Regulatory News (FRP)

Share Price Information for Frp Advisory Group (FRP)

Share Price is delayed by 15 minutes
Get Live Data
117.00    4.00 (3.54%)
Bid:
116.00
Ask:
118.00
Spread: 2.00 (1.724%)
Market Cap: £289.10m
FRP Live PriceLast checked at - London Stock Exchange

Intraday Frp Advisory Group Share Chart

Q3 Dividend Declaration

23 Feb 2026 07:00

RNS Number : 9124T
FRP Advisory Group PLC
23 February 2026
 

23 February 2026

FRP ADVISORY GROUP PLC

("FRP", the "Group" or the "Company")

 

Q3 Dividend Declaration

 

FRP Advisory Group plc, a leading national specialist business advisory firm, is pleased to announce that in line with the Company's quarterly dividend policy, the Board declares an interim dividend of 1p per eligible ordinary share for the third quarter of FY 2026 (Q3 2025: 0.95p). The dividend will be paid on 12 June 2026 to shareholders on the register on 15 May 2026, with the ex-dividend date being 14 May 2026.

 

Enquiries:

 

FRP Advisory Group plc

Geoff Rowley, CEO

Jeremy French, COO

Gavin Jones, CFO

Enquiries via Citypress

 

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Stephen Keys / George Lawson / Elysia Bough (Corporate Finance)

Tel: +44 (0) 207 220 0500

 

Berenberg (Joint Broker)

Toby Flaux / James Thompson / Smruthya Ganeshram

+44 (0)20 3207 7800

 

Citypress (Financial Public Relations)

Martin Currie

T: +44 (0)7976291532

Calum Anderson

T: +44(0)7464444660

FRPreporting@citypress.co.uk

 

One Advisory Limited (Company Secretary)

frp@oneadvisory.london

 

Notes to Editors

FRP is a leading national specialist business advisory firm established in 2010. It offers a range of advisory services to companies, lenders, investors and other stakeholders, as well as individuals. These services include:

Restructuring advisory: corporate financial advisory, formal insolvency appointments, informal restructuring advisory, personal insolvency and general advice to all stakeholders.Corporate finance: mergers & acquisitions (M&A), strategic advisory and valuations, financial due diligence, capital raising, special situations M&A and partial exits.Debt advisory: raising and refinancing debt, debt amendments and extensions, restructuring debt, asset based lending and corporate and leveraged debt advisory.Forensic services: forensic investigations, compliance and risk advisory, dispute services and forensic technology.Financial advisory: transaction services including pre-IPO financial services, financial due diligence, lender services, financial modelling, valuations, pensions and company-side advisory services and corporate governance advisory. 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVSEAFASEMSEDE
Date   Source Headline
3rd Jul 20247:00 amRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
28th May 20244:35 pmRNSHolding(s) in Company
28th May 20244:30 pmRNSHolding(s) in Company
24th May 20247:00 amRNSResult of Placing
23rd May 20244:30 pmRNSProposed Secondary Placing & Lock-in Extension
17th May 20247:00 amRNSFull Year Trading Update
13th May 20247:00 amRNSAcquisition of Hilton-Baird Group
1st May 20242:09 pmRNSHolding(s) in Company
26th Apr 20247:00 amRNSDirectorate Change
28th Mar 20247:00 amRNSTotal Voting Rights
11th Mar 20247:00 amRNSAcquisition of GWC
29th Feb 202410:33 amRNSHolding(s) in Company
16th Feb 20241:45 pmRNSDirector/PDMR Shareholding
14th Feb 20247:00 amRNSQ3 Trading Update and Dividend Declaration
4th Jan 20245:17 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSChair succession
12th Dec 20237:00 amRNSHalf-year Report
17th Nov 20237:00 amRNSHalf Year Trading Update
24th Oct 20235:40 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSChange of Nominated Adviser and Joint Broker
29th Sep 20237:00 amRNSTotal Voting Rights
28th Sep 202312:02 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM Statement and Q1 Dividend Declaration
12th Sep 20237:00 amRNSAcquisition of Wilson Field Group
29th Aug 20237:00 amRNSNotice of AGM
15th Aug 20232:53 pmRNSAward of Share Options / PDMR Notification
11th Aug 20237:00 amRNSAnnual Report & Accounts
10th Aug 202310:42 amRNSHolding(s) in Company
28th Jul 20232:46 pmRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSFull Year Results
15th May 20237:00 amRNSFull Year Trading Update
31st Mar 202310:48 amRNSTotal Voting Rights
24th Mar 20231:55 pmRNSPDMR Dealings and Total Voting Rights
14th Mar 20237:00 amRNSDirector/PDMR Shareholding
10th Mar 20235:28 pmRNSTransfer of Ordinary Shares from EBT
1st Mar 20237:00 amRNSDirectorate Change
13th Feb 202312:08 pmRNSHolding(s) in Company
13th Feb 20237:00 amRNSTrading Update and Q3 Dividend Declaration
9th Jan 20237:00 amRNSAppointment of Joint Broker
30th Dec 20227:00 amRNSTotal Voting Rights
13th Dec 20227:00 amRNSHalf-year Report
7th Dec 20227:00 amRNSAcquisition of APP in Cyprus
11th Nov 20227:00 amRNSHalf Year Trading Update
15th Sep 202212:56 pmRNSResult of Annual General Meeting
15th Sep 20227:00 amRNSAGM Statement and Q1 Dividend Declaration
31st Aug 20229:00 amRNSDirector/PDMR Shareholding
25th Aug 202211:55 amRNSHolding(s) in Company
25th Aug 202211:55 amRNSHolding(s) in Company
12th Aug 20225:00 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.